| P50 | author | Glen M. Doniger | Q48635974 |
| P2093 | author name string | Ely S Simon | |
| | Jeremy D Kark | |
| | Ronit Sinnreich | |
| | James D Otvos | |
| | Irit Cohen-Manheim | |
| | Ronit Pinchas-Mizrachi | |
| P2860 | cites work | Cognitive decline and markers of inflammation and hemostasis: the Edinburgh Artery Study. | Q51975386 |
| | Inflammation markers in relation to cognition in a healthy aging population. | Q52008621 |
| | Effects of older age on fibrin D-dimer, C-reactive protein, and other hemostatic and inflammatory variables in men aged 60-79 years | Q57416334 |
| | Taq1B CETP polymorphism, plasma CETP, lipoproteins, apolipoproteins and sex differences in a Jewish population sample characterized by low HDL-cholesterol | Q74106132 |
| | Financial loss in pyramid savings schemes, downward social mobility and acute coronary syndrome in transitional Albania | Q81469073 |
| | Relations of serum high-sensitivity C-reactive protein and interleukin-6 levels with silent brain infarction | Q81475541 |
| | White blood cell count and psychomotor cognitive performance in the elderly | Q83784631 |
| | Inflammatory markers and the risk of Alzheimer disease: the Framingham Study | Q40208679 |
| | Immunoradiometric assay of circulating C-reactive protein: age-related values in the adult general population. | Q40757294 |
| | White matter correlates of cognitive domains in normal aging with diffusion tensor imaging | Q41215485 |
| | IL-10 alters immunoproteostasis in APP mice, increasing plaque burden and worsening cognitive behavior. | Q42174144 |
| | Improvement of memory impairments in poststroke patients by hyperbaric oxygen therapy | Q43920363 |
| | High-sensitivity C-reactive protein and cognitive function in older women | Q44200496 |
| | Socioeconomic gradients in immune response to latent infection. | Q46699727 |
| | Inflammatory proteins in plasma and the risk of dementia: the rotterdam study | Q47591273 |
| | Intrathecal release of pro- and anti-inflammatory cytokines during stroke. | Q48576539 |
| | Evidence of multidomain mild cognitive impairment in idiopathic intracranial hypertension. | Q50613984 |
| | Systemic markers of inflammation and cognitive decline in old age. | Q50804243 |
| | The Jerusalem Lipid Research Clinic: sampling, response and selected methodological issues. | Q51649238 |
| | Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. | Q51679983 |
| | Haemorheological predictors of cognitive decline: the Edinburgh Artery Study. | Q51887572 |
| | Serum inflammatory proteins and cognitive decline in older persons. | Q51930816 |
| | Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association | Q22241929 |
| | Validity of a novel computerized cognitive battery for mild cognitive impairment | Q24792850 |
| | The hospital anxiety and depression scale | Q27860968 |
| | Interleukin-6 and C-reactive protein as predictors of cognitive decline in late midlife | Q34079309 |
| | Role of inflammation in cognitive impairment: results of observational epidemiological studies and clinical trials | Q34144290 |
| | Inflammation and rate of cognitive change in high-functioning older adults | Q34187062 |
| | Associations between inflammation and cognitive function in African Americans and European Americans | Q34729552 |
| | Cytokines and cognition--the case for a head-to-toe inflammatory paradigm | Q35020920 |
| | Lifestyle factors associated with cognitive functioning in breast cancer survivors | Q35027932 |
| | Inflammatory markers and neuropsychological functioning: the Framingham Heart Study | Q35123609 |
| | Il10 deficiency rebalances innate immunity to mitigate Alzheimer-like pathology | Q35155067 |
| | Association of C-reactive protein with cognitive impairment | Q35591752 |
| | Energy intake and leukocyte telomere length in young adults | Q35677303 |
| | Timing of onset of cognitive decline: results from Whitehall II prospective cohort study. | Q35761935 |
| | Interleukin-6 and C-Reactive Protein Levels and 9-Year Cognitive Decline in Community-Dwelling Older Women: The Women's Health and Aging Study II. | Q35784869 |
| | Lower cognitive performance in healthy G2019S LRRK2 mutation carriers | Q36198611 |
| | Long-term assessment of inflammation and healthy aging in late life: the Cardiovascular Health Study All Stars | Q36215688 |
| | The role of peripheral inflammatory markers in dementia and Alzheimer's disease: a meta-analysis | Q36957501 |
| | Inflammatory markers and cognitive function in middle-aged adults: the Whitehall II study | Q37035931 |
| | Evidence for a cytokine model of cognitive function | Q37321439 |
| | Applications of technology in neuropsychological assessment | Q37407597 |
| | Alzheimer's dementia begins as a disease of small blood vessels, damaged by oxidative-induced inflammation and dysregulated amyloid metabolism: implications for early detection and therapy | Q37826006 |
| | Association between circulating hemostatic measures and dementia or cognitive impairment: systematic review and meta-analyzes. | Q37890043 |
| | Obesity, inflammation and the immune system | Q37994924 |
| | Cigarette smoking and inflammation revisited | Q38078690 |
| | GlycA: A Composite Nuclear Magnetic Resonance Biomarker of Systemic Inflammation | Q38387364 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e0138036 | |
| P577 | publication date | 2015-09-25 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Increase in the Inflammatory Marker GlycA over 13 Years in Young Adults Is Associated with Poorer Cognitive Function in Midlife | |
| P478 | volume | 10 | |